Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing

Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing

Tamara Gracia-Cazaña,* Laura Bernal-Masferrer,* Ana María Morales-Callaghan, Manuel Almenara-Blasco, Yolanda Gilaberte Dermatology Service, Hospital Miguel Servet, IIS Aragon, Zaragoza University, Zaragoza, Spain*These authors contributed equally to this workCorrespondence: T...

Full description

Bibliographic Details
Main Authors: Gracia-Cazaña T, Bernal-Masferrer L, Morales-Callaghan AM, Almenara-Blasco M, Gilaberte Y
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
risankizumab
health related quality of life
psoriasis
Online Access:https://www.dovepress.com/risankizumab-for-the-treatment-of-moderate-to-severe-psoriasis-impact--peer-reviewed-fulltext-article-CCID

Similar Items

Similar Items